|
Rheumatology News, Internal Medicine News,
and Family Practice News present the 3rd annual
Perspectives
in Rheumatic Diseases, a
continuing medical education conference that explores the latest advances in the
treatment and management of rheumatic diseases. This activity has been designed
to provide a forum for rheumatologists, family practice physicians, internists,
nurses, nurse practitioners and physician assistants to receive relevant and
timely information regarding the most recent developments in managing patients
with rheumatic diseases.
By remaining current on the advances in the treatment of rheumatic
diseases—particularly the newest evidence regarding the optimum use of the
biologic agents—clinicians will be able to always provide state-of-the-art
therapeutic options to their patients |
|
Please join us and a nationally renowned group of faculty
leaders as we analyze the many areas of research relevant to rheumatoid
arthritis (RA), psoriasis and psoriatic arthritis, gout, fibromyalgia, lupus,
systemic sclerosis and pulmonary hypertension, vasculitis as well as rheumatic
diseases in children. All sessions are not only science-based lectures from
leading experts, but they also provide an opportunity for interactive cases
studies and panel discussions. This seminar will help clinicians who manage patients with
various rheumatic diseases to maintain and improve their clinical diagnostic and
therapeutic skills, thereby leading to improved patient care and optimal patient
outcomes. |
LEARNING OBJECTIVES
At the conclusion of this conference, participants will be able to
-
Identify recent advances in the diagnosis, management and treatment of rheumatoid arthritis as well as new pathways being targeted in therapy.
-
Describe the long-term safety and efficacy of biologic and other systemic agents in the treatment of rheumatoid arthritis, psoriasis and psoriatic arthritis.
-
Explain the connection between rheumatic diseases and cardiovascular risk.
-
Outline the clinical course of SLE and cutaneous lupus; explain the importance and benefit of early treatment.
-
Identify the aspects of care, treatment, and overall outcomes that are important in the management of pediatric patients with rheumatic diseases
-
Identify and describe the clinical manifestations and complications of systemic sclerosis and pulmonary hypertension.
-
Develop a strategy for a diagnostic workup to accurately establish (or rule out) fibromyalgia as a cause of a patient’s symptoms
-
Apply the most current information regarding the risk factors for, the clinical manifestations of, and the cutting-edge treatments for hyperuricemia and gout.
-
Compare and contrast the efficacy and safety profiles of pharmacologic therapeutic options for osteoarthritis and identify their limitations.
|
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Louisville (CHSE) and Skin Disease Education Foundation (SDEF). CHSE is accredited by the ACCME to provide continuing medical education (CME) for physicians.
|
AMA PRA CREDIT DESIGNATION STATEMENT
The CHSE designates this educational activity for a maximum of 12 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
AAFP Credit
This activity has been reviewed and is acceptable
for up to 11.75 Prescribed credits by the American Academy of Family Physicians.
|
AMA/AAFP EQUIVALENCY
AAFP Prescribed credit is accepted by the American Medical
Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA
Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit
earned must be reported as Prescribed credit, not as Category 1.
|
NURSING CREDIT
This program has been approved by the Kentucky Board of Nursing for 14.4 contact hours through the University of Louisville School of Nursing, provider number 3-0046-01-2013-134, expiration date January 31, 2013. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content. Participants must complete entire session, provide license and social security number and complete the online evaluation to receive contact hours.
|
FACULTY DISCLOSURE
As a sponsor accredited by the ACCME, it is the policy of the CHSE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with either the commercial supporter(s) of this activity or the manufacturer(s) of any commercial product(s) discussed in an educational presentation. Such disclosure will be made available on the day of the program.
|
|
|
